179 related articles for article (PubMed ID: 9266785)
1. Increasing age is a major risk factor for hemorrhagic complications after pulmonary embolism thrombolysis.
Mikkola KM; Patel SR; Parker JA; Grodstein F; Goldhaber SZ
Am Heart J; 1997 Jul; 134(1):69-72. PubMed ID: 9266785
[TBL] [Abstract][Full Text] [Related]
2. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
[TBL] [Abstract][Full Text] [Related]
3. [Fibrinolysis in pulmonary embolism].
Thabut G; Jebrak G
Presse Med; 2001 Oct; 30(30):1501-6. PubMed ID: 11712211
[TBL] [Abstract][Full Text] [Related]
4. Incidence and predictors of major hemorrhagic complications from thrombolytic therapy in patients with massive pulmonary embolism.
Meyer G; Gisselbrecht M; Diehl JL; Journois D; Sors H
Am J Med; 1998 Dec; 105(6):472-7. PubMed ID: 9870831
[TBL] [Abstract][Full Text] [Related]
5. Thrombolysis vs heparin in the treatment of pulmonary embolism: a clinical outcome-based meta-analysis.
Agnelli G; Becattini C; Kirschstein T
Arch Intern Med; 2002 Dec 9-23; 162(22):2537-41. PubMed ID: 12456225
[TBL] [Abstract][Full Text] [Related]
6. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.
Ouriel K; Veith FJ; Sasahara AA
N Engl J Med; 1998 Apr; 338(16):1105-11. PubMed ID: 9545358
[TBL] [Abstract][Full Text] [Related]
7. Catheter-directed, ultrasound-assisted thrombolysis is a safe and effective treatment for pulmonary embolism, even in high-risk patients.
Lee KA; Cha A; Kumar MH; Rezayat C; Sales CM
J Vasc Surg Venous Lymphat Disord; 2017 Mar; 5(2):165-170. PubMed ID: 28214482
[TBL] [Abstract][Full Text] [Related]
8. Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis.
Ouriel K; Gray B; Clair DG; Olin J
J Vasc Interv Radiol; 2000 Mar; 11(3):295-8. PubMed ID: 10735422
[TBL] [Abstract][Full Text] [Related]
9. [Complications of thrombolytic therapy in pulmonary embolism].
Meneveau N; Vuillemenot A; Bassand JP
Arch Mal Coeur Vaiss; 1995 Nov; 88(11 Suppl):1769-76. PubMed ID: 8815838
[TBL] [Abstract][Full Text] [Related]
10. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
Dalen JE; Alpert JS; Hirsh J
Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
[No Abstract] [Full Text] [Related]
11. Thrombolytic therapy of pulmonary embolism: a meta-analysis.
Thabut G; Thabut D; Myers RP; Bernard-Chabert B; Marrash-Chahla R; Mal H; Fournier M
J Am Coll Cardiol; 2002 Nov; 40(9):1660-7. PubMed ID: 12427420
[TBL] [Abstract][Full Text] [Related]
12. Extensive experience with dural sinus thrombosis.
Soleau SW; Schmidt R; Stevens S; Osborn A; MacDonald JD
Neurosurgery; 2003 Mar; 52(3):534-44; discussion 542-4. PubMed ID: 12590677
[TBL] [Abstract][Full Text] [Related]
13. Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
Weaver WD; White HD; Wilcox RG; Aylward PE; Morris D; Guerci A; Ohman EM; Barbash GI; Betriu A; Sadowski Z; Topol EJ; Califf RM
JAMA; 1996 Mar; 275(10):777-82. PubMed ID: 8598594
[TBL] [Abstract][Full Text] [Related]
14. Thrombolytic therapy for pulmonary embolism.
Katchan BM
Can J Surg; 2000 Dec; 43(6):411-6. PubMed ID: 11129828
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis.
Chatterjee S; Chakraborty A; Weinberg I; Kadakia M; Wilensky RL; Sardar P; Kumbhani DJ; Mukherjee D; Jaff MR; Giri J
JAMA; 2014 Jun; 311(23):2414-21. PubMed ID: 24938564
[TBL] [Abstract][Full Text] [Related]
16. [Safe dose rTPA for massive pulmonary embolism associated with high bleeding risk: a case report and review of the literature].
Mele M; Mele A; La Torre PP; Cannone M
G Ital Cardiol (Rome); 2014 Apr; 15(4):240-3. PubMed ID: 24873813
[TBL] [Abstract][Full Text] [Related]
17. Thrombolytic therapy in pulmonary embolism.
Goldhaber SZ; Bounameaux H
Semin Vasc Med; 2001 Nov; 1(2):213-20. PubMed ID: 15199505
[TBL] [Abstract][Full Text] [Related]
18. In-hospital and long-term outcome after sub-massive and massive pulmonary embolism submitted to thrombolytic therapy.
Meneveau N; Ming LP; Séronde MF; Mersin N; Schiele F; Caulfield F; Bernard Y; Bassand JP
Eur Heart J; 2003 Aug; 24(15):1447-54. PubMed ID: 12909074
[TBL] [Abstract][Full Text] [Related]
19. Contemporary pulmonary embolism thrombolysis.
Goldhaber SZ
Chest; 1995 Jan; 107(1 Suppl):45S-51S. PubMed ID: 7813329
[TBL] [Abstract][Full Text] [Related]
20. Randomized, controlled trial of ultrasound-assisted catheter-directed thrombolysis for acute intermediate-risk pulmonary embolism.
Kucher N; Boekstegers P; Müller OJ; Kupatt C; Beyer-Westendorf J; Heitzer T; Tebbe U; Horstkotte J; Müller R; Blessing E; Greif M; Lange P; Hoffmann RT; Werth S; Barmeyer A; Härtel D; Grünwald H; Empen K; Baumgartner I
Circulation; 2014 Jan; 129(4):479-86. PubMed ID: 24226805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
